2020 |
05/01 | 15:40 行使価額修正条項付新株予約権の行使価額の修正に関するお知らせ |
04/28 | 688 | 718 | 684 | 718 | +4.66% | 52,800 | 49億684万 | +20.27% |
04/27 | 685 | 704 | 682 | 686 | +0.73% | 36,500 | 46億8815万 | +16.47% |
04/24 | 685 | 700 | 671 | 681 | -0.58% | 45,100 | 46億5398万 | +17.01% |
04/23 | 657 | 697 | 657 | 685 | +4.74% | 61,100 | 46億8131万 | +18.92% |
04/22 | 654 | 662 | 635 | 654 | -2.53% | 48,000 | 44億6946万 | +14.94% |
04/21 | 713 | 718 | 656 | 671 | -5.23% | 122,600 | 45億8564万 | +18.97% |
04/20 | 670 | 721 | 670 | 708 | +4.12% | 93,300 | 48億3850万 | +27.34% |
04/17 | 640 | 688 | 636 | 680 | +7.94% | 142,000 | 46億4714万 | +24.31% |
04/16 | 616 | 639 | 616 | 630 | +1.45% | 63,700 | 43億544万 | +16.45% |
04/15 | 600 | 629 | 599 | 621 | +1.8% | 72,400 | 42億4393万 | +15.21% |
04/14 | 585 | 614 | 581 | 610 | +6.09% | 101,400 | 41億6876万 | +13.17% |
04/13 | 568 | 585 | 565 | 575 | +0.52% | 52,400 | 39億2957万 | +6.68% |
04/10 | 589 | 589 | 560 | 572 | -1.21% | 38,400 | 39億907万 | +4.76% |
04/09 | 560 | 580 | 558 | 579 | +4.14% | 59,000 | 39億5690万 | +4.51% |
04/08 | 536 | 570 | 527 | 556 | +2.21% | 43,100 | 37億9972万 | -1.07% |
04/07 | 530 | 559 | 527 | 544 | +4.21% | 70,500 | 37億1771万 | -4.39% |
04/06 | 490 | 523 | 484 | 522 | +5.45% | 95,100 | 35億6736万 | -9.53% |
04/03 | 521 | 521 | 495 | 495 | -3.13% | 69,900 | 33億8284万 | -15.09% |
04/02 | 511 | 529 | 510 | 511 | -0.78% | 48,500 | 34億9219万 | -13.39% |
04/01 | 527 | 544 | 515 | 515 | -4.1% | 56,300 | 35億1953万 | -14.17% |
03/31 | 572 | 572 | 530 | 537 | +3.87% | 105,300 | 36億6987万 | -11.97% |
03/30 | 15:00 ASCO年次総会におけるCBP501臨床試験データ発表について |
03/30 | 510 | 528 | 505 | 517 | -3.54% | 82,600 | 35億3319万 | -16.75% |
03/27 | 560 | 560 | 528 | 536 | -0.92% | 64,400 | 36億6304万 | -15.32% |
03/26 | 555 | 569 | 541 | 541 | -5.91% | 65,200 | 36億9721万 | -16.12% |
03/25 | 568 | 575 | 544 | 575 | +8.9% | 145,700 | 39億2957万 | -12.35% |
03/24 | 16:05 新型コロナウイルス感染症(COVID-19)に関する影響について |
03/24 | 527 | 538 | 513 | 528 | +3.53% | 61,900 | 36億837万 | -20.96% |
03/23 | 510 | 530 | 499 | 510 | -1.35% | 84,500 | 34億8536万 | -25.22% |
03/19 | 539 | 539 | 509 | 517 | -0.39% | 69,300 | 35億3319万 | -25.72% |
03/18 | 538 | 565 | 519 | 519 | -1.7% | 127,900 | 35億4686万 | -27.11% |
03/17 | 16:25 ファルマバレープロジェクトとの共同研究契約(2件)の期間延長のお知らせ |
03/17 | 465 | 530 | 460 | 528 | +8.87% | 189,300 | 36億837万 | -27.47% |
03/16 | 476 | 531 | 465 | 485 | +3.63% | 186,200 | 33億1450万 | -34.81% |
03/13 | 488 | 507 | 437 | 468 | -12.52% | 350,500 | 31億9833万 | -38.58% |
03/12 | 571 | 600 | 531 | 535 | -7.92% | 248,400 | 36億5621万 | -31.5% |
03/11 | 604 | 637 | 581 | 581 | -4.6% | 107,900 | 39億7057万 | -27.1% |
03/10 | 531 | 627 | 528 | 609 | -1.93% | 246,700 | 41億6193万 | -25% |
03/09 | 11:35 CBP501フェーズ1b試験拡大相(膵臓癌)組入れ完了見通し遅延のお知らせ |
03/09 | 693 | 705 | 610 | 621 | -15.85% | 280,400 | 42億4393万 | -24.73% |
03/06 | 758 | 769 | 731 | 738 | -5.38% | 90,100 | 50億4352万 | -11.62% |
03/05 | 810 | 821 | 770 | 780 | -0.26% | 126,000 | 53億3055万 | -7.58% |
03/04 | 707 | 825 | 707 | 782 | +8.61% | 245,900 | 53億4421万 | -8.32% |
03/03 | 879 | 890 | 712 | 720 | -5.14% | 348,500 | 49億2050万 | -16.47% |
03/02 | 754 | 759 | 702 | 759 | +15.17% | 120,300 | 51億8703万 | -13.06% |
02/28 | 15:20 CBP501フェーズ1b試験拡大相(膵臓癌)組入れ完了見通しのお知らせ |
02/28 | 649 | 694 | 646 | 659 | -4.35% | 262,600 | 45億363万 | -25.37% |
02/27 | 16:00 転換社債の一部譲渡に関するお知らせ |
02/27 | 753 | 753 | 689 | 689 | -6.77% | 204,400 | 47億865万 | -23.1% |
02/26 | 766 | 776 | 720 | 739 | -5.26% | 153,200 | 50億5035万 | -18.52% |
02/25 | 732 | 799 | 732 | 780 | -3.35% | 138,700 | 53億3055万 | -14.85% |
02/21 | 810 | 822 | 800 | 807 | -0.98% | 75,800 | 55億1507万 | -12.38% |
02/20 | 838 | 838 | 800 | 815 | -2.74% | 96,300 | 55億6974万 | -11.99% |
02/19 | 825 | 856 | 824 | 838 | +1.45% | 90,800 | 57億2692万 | -9.8% |
02/18 | 850 | 862 | 817 | 826 | -3.39% | 129,700 | 56億4491万 | -11.28% |
02/17 | 870 | 877 | 853 | 855 | -2.73% | 77,900 | 58億4310万 | -8.46% |
02/14 | 873 | 881 | 860 | 879 | -0.45% | 86,300 | 60億712万 | -5.99% |
02/13 | 924 | 925 | 875 | 883 | -2.97% | 107,000 | 60億3445万 | -5.36% |
02/12 | 15:00 2020年6月期第2四半期決算短信〔日本基準〕(非連結) |
02/12 | 15:00 営業外損益の計上に関するお知らせ |
02/12 | 912 | 916 | 890 | 910 | -0.22% | 44,800 | 62億1897万 | -2.47% |
02/10 | 907 | 922 | 898 | 912 | -0.65% | 71,800 | 62億3264万 | -2.15% |
02/07 | 931 | 947 | 914 | 918 | -2.96% | 70,300 | 62億7364万 | -1.4% |
02/06 | 951 | 955 | 925 | 946 | +1.07% | 79,300 | 64億6500万 | +1.61% |
02/05 | 951 | 978 | 930 | 936 | -1.58% | 76,200 | 63億9666万 | +0.54% |
02/04 | 944 | 964 | 926 | 951 | +0.96% | 87,400 | 64億9917万 | +2.26% |
02/03 | 890 | 946 | 890 | 942 | +1.29% | 92,000 | 64億3766万 | +1.62% |
01/31 | 918 | 945 | 904 | 930 | +4.14% | 112,700 | 63億5565万 | +0.54% |
01/30 | 933 | 948 | 881 | 893 | -6.78% | 246,500 | 61億279万 | -3.46% |
01/29 | 995 | 1,007 | 956 | 958 | -4.1% | 138,100 | 65億4701万 | +3.57% |
01/28 | 968 | 1,009 | 968 | 999 | +0.3% | 137,400 | 68億2720万 | +8.35% |
01/27 | 15:00 第2四半期及び通期業績予想の再修正に関するお知らせ |
01/27 | 968 | 1,013 | 963 | 996 | -0.2% | 117,700 | 68億670万 | +8.5% |
01/24 | 998 | 1,010 | 974 | 998 | -0.6% | 98,100 | 68億2037万 | +9.19% |
01/23 | 1,006 | 1,020 | 987 | 1,004 | +1.31% | 96,700 | 68億6137万 | +10.33% |
01/22 | 968 | 1,029 | 968 | 991 | +2.16% | 260,200 | 67億7253万 | +9.38% |
01/21 | 951 | 970 | 948 | 970 | +1.04% | 73,400 | 66億2901万 | +7.42% |
01/20 | 937 | 974 | 921 | 960 | +5.49% | 182,000 | 65億6067万 | +6.55% |
01/17 | 911 | 922 | 902 | 910 | -1.09% | 53,500 | 62億1897万 | +1% |
01/16 | 901 | 930 | 901 | 920 | +2.11% | 58,800 | 62億8731万 | +1.88% |
01/15 | 888 | 917 | 888 | 901 | +1.01% | 75,000 | 61億5747万 | -0.44% |
01/14 | 889 | 913 | 888 | 892 | +0.22% | 38,900 | 60億9596万 | -1.76% |
01/10 | 868 | 909 | 868 | 890 | +0.79% | 84,700 | 60億8229万 | -2.63% |
01/09 | 863 | 887 | 857 | 883 | +4.62% | 73,700 | 60億3445万 | -4.02% |
01/08 | 867 | 870 | 822 | 844 | -3.87% | 218,500 | 57億6792万 | -8.76% |
01/07 | 871 | 890 | 869 | 878 | +1.39% | 67,600 | 60億28万 | -5.79% |
01/06 | 888 | 902 | 862 | 866 | -4.31% | 128,900 | 59億1827万 | -7.58% |
2019 |
12/30 | 896 | 925 | 891 | 905 | -0.66% | 98,700 | 61億8480万 | -3.83% |
12/27 | 945 | 945 | 911 | 911 | -2.88% | 125,000 | 62億2581万 | -3.29% |
12/26 | 924 | 949 | 915 | 938 | +2.63% | 134,800 | 64億1032万 | -0.53% |
12/25 | 885 | 928 | 885 | 914 | +2.24% | 135,600 | 62億4631万 | -2.87% |
12/24 | 878 | 901 | 878 | 894 | +1.59% | 72,600 | 61億963万 | -4.79% |
12/23 | 920 | 929 | 879 | 880 | -4.35% | 168,300 | 60億1395万 | -6.18% |
12/20 | 908 | 940 | 901 | 920 | +2.45% | 187,000 | 62億8731万 | -1.81% |
12/19 | 882 | 903 | 882 | 898 | +0.56% | 93,900 | 61億3696万 | -3.75% |
12/18 | 901 | 914 | 879 | 893 | -1% | 116,400 | 61億279万 | -3.98% |
12/17 | 880 | 903 | 866 | 902 | +2.15% | 146,100 | 61億6430万 | -2.7% |
12/16 | 884 | 912 | 872 | 883 | -1.67% | 145,000 | 60億3445万 | -4.44% |
12/13 | 900 | 920 | 891 | 898 | -1.21% | 143,900 | 61億3696万 | -2.71% |
12/12 | 920 | 920 | 888 | 909 | -1.41% | 183,200 | 62億1214万 | -1.3% |
12/11 | 930 | 948 | 898 | 922 | -0.22% | 217,300 | 63億98万 | +0.22% |
12/10 | 946 | 957 | 924 | 924 | -1.49% | 131,600 | 63億1465万 | +0.87% |
12/09 | 982 | 986 | 930 | 938 | -3% | 223,300 | 64億1032万 | +2.85% |
12/06 | 968 | 989 | 958 | 967 | -1.63% | 140,400 | 66億851万 | +6.5% |
12/05 | 973 | 1,018 | 959 | 983 | +1.34% | 239,700 | 67億1786万 | +9.1% |
12/04 | 1,030 | 1,050 | 966 | 970 | -6.73% | 411,600 | 66億2901万 | +8.5% |
12/03 | 16:15 (訂正・数値データ訂正)「事業進捗見通しの修正及びこれに伴う第2四半期及び通期業績予想の修正に関するお知らせ」の一部訂正について |
12/03 | 998 | 1,068 | 990 | 1,040 | +0.39% | 304,300 | 71億740万 | +17.12% |
12/02 | 16:00 事業進捗見通しの修正及びこれに伴う第2四半期及び通期業績予想の修正に関するお知らせ |
12/02 | 1,013 | 1,039 | 1,001 | 1,036 | +3.08% | 193,500 | 70億8006万 | +18% |
11/29 | 1,030 | 1,040 | 993 | 1,005 | -2.99% | 217,600 | 68億6821万 | +15.65% |